Thomas Matthew Habermann, MD


  • 18478 Citations
  • 69 h-Index
1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 17 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1978 2017

Lymphoma Specialized Program of Research Excellence

Macon, W. R., Dogan, A. M., Ansell, S. M., Gupta, M. D., Witzig, T. E., Cerhan, J. R., Habermann, T. M., Ratliff, T. L., Link, B. K., Ratliff, T. L., Juweid, M., Ballas, Z., Link, B. K., Ratliff, T., Geyer, S. M., Weiner, G., Lentz, S., Hohl, R. & Smith, B. J.

National Institutes of Health


Project: Research projectSpecialized Center

Non-Hodgkin's Lymphoma
Molecular Epidemiology
B-Cell Lymphoma


Habermann, T. M., Hahn, R. & Edmonson, J.

National Institutes of Health


Project: Research projectCooperative Clinical Research--Cooperative Agreements

Antineoplastic Protocols
Organized Financing
Clinical Protocols

Research Output 1983 2019

Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts

Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Cause of Death
Disease-Free Survival
1 Citations

Acute coronary syndromes in patients with active hematologic malignancies – Incidence, management, and outcomes

Park, J. Y., Guo, W., Al-Hijji, M., El Sabbagh, A., Begna, K. H., Habermann, T. M., Witzig, T. E., Lewis, B. R., Lerman, A. & Herrmann, J., Jan 1 2018, (Accepted/In press) In : International Journal of Cardiology.

Research output: Contribution to journalArticle

Hematologic Neoplasms
Acute Coronary Syndrome
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1 Citations

A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers

Tolcher, A., Flaherty, K., Shapiro, G. I., Berlin, J., Witzig, T. E., Habermann, T. M., Bullock, A., Rock, E., Elekes, A., Lin, C., Kostic, D., Ohi, N., Rasco, D., Papadopoulos, K. P., Patnaik, A., Smith, L. & Cote, G. M., Jun 1 2018, In : Oncologist. 23, 6, p. 658-e72

Research output: Contribution to journalArticle

Oxidative Phosphorylation
Lymphoma, Large B-Cell, Diffuse

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Maximum Tolerated Dose
Hodgkin Disease

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Peripheral Nervous System Diseases